Antimicrobial susceptibility testing (AST) is a diagnostic test that helps determine the most effective antibiotic for the treatment of bacterial infections. This test is essential in controlling the spread of antibiotic-resistant bacteria, which have become a significant global health concern. The global antimicrobial susceptibility testing market is growing at a steady pace and is expected to continue to grow in the future.
North America dominated the market in 2020, accounting for the largest share of the market. The region is expected to continue to dominate the market during the forecast period due to the increasing incidence of infectious diseases and rising demand for rapid and accurate diagnostic tests.
antimicrobial susceptibility testing market size is expected to reach ~USD 3 billion by 2028, growing at a CAGR of +5% during forecast period
The major trends driving the growth of the antimicrobial susceptibility testing market include increasing incidence of infectious diseases, rising demand for rapid and accurate diagnostic tests, increasing adoption of automated AST systems, and increasing focus on developing personalized medicine. The increasing prevalence of infectious diseases, such as COVID-19, has created a significant demand for rapid diagnostic tests, including AST tests. Moreover, the growing adoption of automated AST systems, which can deliver accurate and rapid results, is driving the market growth.
The key opportunities in the antimicrobial susceptibility testing market include increasing demand for personalized medicine, the development of new antibiotics, and growing awareness about the importance of AST tests. However, the market growth is hampered by factors such as high costs associated with AST tests, lack of skilled professionals, and the limited availability of diagnostic tools in developing countries.
The regulatory and legal issues affecting the antimicrobial susceptibility testing market include the stringent regulatory framework for diagnostic tests and the increasing focus on improving the quality of diagnostic tests. The US Food and Drug Administration (FDA) has established a regulatory framework to ensure the safety and efficacy of diagnostic tests. Similarly, the European Medicines Agency (EMA) has established regulations to ensure the quality, safety, and efficacy of diagnostic tests.
The target demographics of the antimicrobial susceptibility testing market include hospitals, clinical laboratories, pharmaceutical companies, and research institutes. Hospitals and clinical laboratories are the largest end-users of AST tests due to the high incidence of infectious diseases in these settings.
The pricing trends in the antimicrobial susceptibility testing market vary across different segments. The cost of AST tests is generally high due to the complex nature of the test and the need for specialized equipment and skilled professionals. However, the increasing adoption of automated AST systems is expected to drive down the cost of the test in the future.
The global antimicrobial susceptibility testing market is growing at a steady pace, driven by increasing incidence of infectious diseases, rising demand for rapid and accurate diagnostic tests, and increasing adoption of automated AST systems.
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
AI® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market